Chevet, Baptiste https://orcid.org/0000-0002-9646-7603
Boscato Sopetto, Giulia https://orcid.org/0009-0006-9272-1703
Pagnoux, Christian https://orcid.org/0000-0001-6287-9549
Specks, Ulrich https://orcid.org/0000-0002-6559-1206
Berti, Alvise https://orcid.org/0000-0002-7831-921X
Cornec, Divi https://orcid.org/0000-0002-9159-702X
Funding for this research was provided by:
Vasculitis Foundation (N&A)
Università degli Studi di Trento
Article History
Accepted: 15 April 2025
First Online: 31 May 2025
Declarations
:
: Open access funding provided by Università degli Studi di Trento within the CRUI-CARE Agreement. This study was supported by a research grant from the Vasculitis foundation to Dr. Alvise Berti ().
: Dr. U. Specks has received research grants from Amgen, AstraZeneca, GSK, Genentech/Roche, NorthStar Medical Radioisotopes, Novartis, and NS Pharma and consulting and advisory board fees from Amgen, AstraZeneca, Argenx, BoehringerIngelheim, CSL Vifor, and Novartis, all unrelated to the present publication. Dr. A. Berti has served on advisory boards and has received lecturing fees from GSK, all unrelated to the present publication. Dr. D. Cornec, Dr. Giulia Boscato Sopetto, and Dr. Baptiste Chevet have no personal conflicts of interest. Dr. C. Pagnoux has received fees unrelated to the present publication for serving on advisory boards from Chemocentryx, Otsuka, GlaxoSmithKline, AstraZeneca, NeoVii, and Hoffman-LaRoche; for lecture fees from Hoffman-La Roche, GlaxoSmithKline; and educational grant support from Hoffman-La Roche, Otsuka, Pfizer, and GlaxoSmithKline.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: B.C. and G.B.S. drafted the first version of the manuscript. D.C. and A.B. contributed to the study conception and design and supervised the writing. U.S. and C.P. reviewed the second version of the paper. All authors discussed the results, commented on the manuscript, and approved the final version.